Liver injury in COVID-19 patients with non-alcoholic fatty liver disease: an update.

coronavirus disease 2019 liver injury nonalcoholic fatty liver disease severe acute respiratory syndrome coronavirus 2

Journal

Archives of medical sciences. Atherosclerotic diseases
ISSN: 2451-0629
Titre abrégé: Arch Med Sci Atheroscler Dis
Pays: Poland
ID NLM: 101701205

Informations de publication

Date de publication:
2023
Historique:
received: 24 09 2022
accepted: 06 02 2023
medline: 8 5 2023
pubmed: 8 5 2023
entrez: 8 5 2023
Statut: epublish

Résumé

The coronavirus disease 2019 (COVID-19) pandemic has revolutionized the priorities of the medical society worldwide. Although most patients infected with SARS-CoV-2 exhibit respiratory symptoms, other organs may also be involved, including the liver, often resulting in liver injury. Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the world, and its prevalence is expected to increase together with the epidemics of type 2 diabetes and obesity. Data about liver injury during COVID-19 are numerous, while overviews of this infection in patients with NAFLD, both in terms of respiratory and liver, are emerging. In this review, we summarise the current research focusing on COVID-19 in NAFLD patients and discuss the association between liver injury in COVID-19 subjects and non-alcoholic fatty liver disease.

Identifiants

pubmed: 37153375
doi: 10.5114/amsad/160950
pii: 160950
pmc: PMC10161789
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e1-e10

Informations de copyright

Copyright: © 2023 Termedia & Banach.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Metabolism. 2019 Mar;92:82-97
pubmed: 30502373
J Hepatol. 2020 Aug;73(2):451-453
pubmed: 32278005
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
Am J Gastroenterol. 2014 Jul;109(7):1020-5
pubmed: 24890439
Lancet Diabetes Endocrinol. 2014 Nov;2(11):901-10
pubmed: 24731669
Diabetes Metab. 2020 Nov;46(6):505-507
pubmed: 32505652
Hepatology. 2005 May;41(5):1151-9
pubmed: 15841464
Diabetes Metab. 2020 Sep;46(4):288-295
pubmed: 31786360
Cells. 2021 Aug 12;10(8):
pubmed: 34440841
Nat Rev Endocrinol. 2018 Feb;14(2):99-114
pubmed: 29286050
Eur J Gastroenterol Hepatol. 2021 Mar 1;33(3):309-311
pubmed: 32558697
Arch Med Sci Atheroscler Dis. 2022 Mar 28;7:e5-e23
pubmed: 35582712
J Endocrinol Invest. 2020 Jun;43(6):867-869
pubmed: 32222956
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Clin Sci (Lond). 2013 Sep;125(6):301-9
pubmed: 23596966
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
J Infect. 2020 Aug;81(2):e16-e25
pubmed: 32335169
Lipids Health Dis. 2021 Oct 3;20(1):126
pubmed: 34602072
Ann Ist Super Sanita. 2017 Jan-Mar;53(1):77-81
pubmed: 28361809
Hepatology. 2016 Jul;64(1):73-84
pubmed: 26707365
J Clin Transl Res. 2017 Feb;3(Suppl 1):212-232
pubmed: 28691103
JHEP Rep. 2019 Feb 23;1(1):30-43
pubmed: 32149275
Liver Int. 2020 May;40(5):998-1004
pubmed: 32170806
Arch Toxicol. 2020 Apr;94(4):1367-1369
pubmed: 32266419
Gastroenterology. 2020 May;158(7):1999-2014.e1
pubmed: 32044314
Int J Obes (Lond). 2018 Apr;42(4):926-929
pubmed: 29437160
J Hepatol. 2020 Sep;73(3):719-721
pubmed: 32348790
Metabolism. 2020 Jul;108:154244
pubmed: 32320741
Hepatology. 2020 Jul;72(1):287-304
pubmed: 32298473
Diabetes Metab Syndr. 2021 May-Jun;15(3):813-822
pubmed: 33862417
CMAJ. 2010 Aug 10;182(11):E526-31
pubmed: 20566726
Metabol Open. 2020 Dec;8:100057
pubmed: 32924000
Biochem Biophys Res Commun. 2014 Aug 22;451(2):208-14
pubmed: 25073113
Adv Pharmacol. 2019;85:75-107
pubmed: 31307592
Nat Rev Gastroenterol Hepatol. 2019 Sep;16(9):517-530
pubmed: 31278377
J Gastroenterol Hepatol. 2011 Mar;26(3):501-9
pubmed: 21332546
Ann Hepatol. 2022 Jan-Feb;27(1):100653
pubmed: 34929350
Dig Liver Dis. 2021 Feb;53(2):153-157
pubmed: 33011088
Liver Int. 2018 Nov;38(11):2060-2068
pubmed: 29577560
J Gastroenterol. 2021 Mar;56(3):218-230
pubmed: 33527211
J Hepatol. 2020 Nov;73(5):1231-1240
pubmed: 32553666
Am J Gastroenterol. 2019 Nov;114(11):1714-1715
pubmed: 31599742
Arch Med Sci Atheroscler Dis. 2021 Apr 06;6:e5-e13
pubmed: 34027207
Gut. 2020 Aug;69(8):1545-1547
pubmed: 32414813
Liver Int. 2020 Oct;40(10):2515-2521
pubmed: 32585065
Eur J Clin Invest. 2020 Oct;50(10):e13362
pubmed: 32726868
Ann Hepatol. 2021 Jan-Feb;20:100271
pubmed: 33099028
J Gastroenterol Hepatol. 2021 Jan;36(1):204-207
pubmed: 32436622
Gastroenterology. 2015 Mar;148(3):547-55
pubmed: 25461851
Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):32-42
pubmed: 27729660
J Hepatol. 2021 Mar;74(3):748-749
pubmed: 33338513
Int J Mol Sci. 2020 Aug 12;21(16):
pubmed: 32806722
United European Gastroenterol J. 2020 Jun;8(5):509-519
pubmed: 32450787
Transl Gastroenterol Hepatol. 2020 Apr 05;5:16
pubmed: 32258520
Liver Int. 2021 Jan;41(1):20-32
pubmed: 33190346
J Med Virol. 2020 Oct;92(10):1818-1824
pubmed: 32437004
Nat Rev Gastroenterol Hepatol. 2013 Jun;10(6):330-44
pubmed: 23507799
Hepatol Commun. 2020 May 21;4(7):953-972
pubmed: 32626829
Am J Emerg Med. 2008 Jul;26(6):711-5
pubmed: 18606328
J Hepatol. 2020 Sep;73(3):566-574
pubmed: 32298767
Nat Rev Gastroenterol Hepatol. 2022 May;19(5):277-278
pubmed: 35301465
Arch Med Res. 2021 Jan;52(1):25-37
pubmed: 33334622
Obes Facts. 2016;9(2):65-90
pubmed: 27055256
Diabetes Metab. 2016 Jun;42(3):142-56
pubmed: 27142870
J Clin Transl Hepatol. 2020 Mar 28;8(1):13-17
pubmed: 32274341
Clin Gastroenterol Hepatol. 2018 Feb;16(2):198-210.e2
pubmed: 28970148
J Diabetes Res. 2016;2016:2931985
pubmed: 27123461
J Hepatol. 2021 Feb;74(2):482-484
pubmed: 33223215
Kans J Med. 2022 Jul 21;15:241-246
pubmed: 35899064
Diabetes Res Clin Pract. 2020 Oct;168:108374
pubmed: 32805345
Clin Res Hepatol Gastroenterol. 2022 May;46(5):101894
pubmed: 35227956
Hepatol Int. 2020 Sep;14(5):690-700
pubmed: 32623632
Lancet Respir Med. 2020 Jun;8(6):e46-e47
pubmed: 32353251
Eur J Gastroenterol Hepatol. 2021 Dec 1;33(12):1578-1581
pubmed: 32868652
Cell Host Microbe. 2020 Jun 10;27(6):883-890.e2
pubmed: 32407669
Nature. 2020 Aug;584(7821):463-469
pubmed: 32717743
Hepatol Commun. 2022 Nov;6(11):3062-3072
pubmed: 34558853
Viral Immunol. 2003;16(1):69-86
pubmed: 12725690
Diabetes Res Clin Pract. 2018 Jan;135:65-72
pubmed: 29097288
Dig Dis Sci. 2021 Sep;66(9):3192-3198
pubmed: 32980956
SN Compr Clin Med. 2020;2(12):2726-2729
pubmed: 33173850
J Hepatol. 2020 Sep;73(3):717-718
pubmed: 32360995
N Engl J Med. 2020 Jun 11;382(24):2327-2336
pubmed: 32275812
Hepatology. 2005 Jul;42(1):44-52
pubmed: 15895401
Nat Rev Gastroenterol Hepatol. 2021 May;18(5):348-364
pubmed: 33692570
J Med Virol. 2021 Jan;93(1):257-261
pubmed: 32603481
Arch Med Sci Atheroscler Dis. 2021 Apr 12;6:e30-e39
pubmed: 34027212
Horm Metab Res. 2022 Aug;54(8):522-531
pubmed: 35468630
J Hepatol. 2022 Oct;77(4):1161-1197
pubmed: 35868584
Front Med (Lausanne). 2021 Mar 12;8:626425
pubmed: 33777974
PLoS One. 2020 Oct 8;15(10):e0240400
pubmed: 33031439
J Hepatol. 2021 Aug;75(2):439-441
pubmed: 33905793
Semin Liver Dis. 2019 Feb;39(1):86-95
pubmed: 30654392
Aliment Pharmacol Ther. 2020 Jul;52(2):267-275
pubmed: 32402090
Hepatol Commun. 2020 Sep 02;4(12):1758-1768
pubmed: 32838108
Abdom Radiol (NY). 2020 Sep;45(9):2748-2754
pubmed: 32683613
World J Clin Cases. 2020 Oct 6;8(19):4303-4310
pubmed: 33083389

Auteurs

Cesare Miranda (C)

Clinic of Endocrinology and Metabolism Diseases, Pordenone Hospital, Pordenone, Italy.

Elena Garlatti (E)

Internal Medicine, Santa Maria degli Angeli Hospital, Pordenone, Italy.

Andrea Da Porto (A)

Department of Medicine, Clinica Medica, University of Udine, Udine, Italy.

Elena Rinaldo (E)

Clinic of Endocrinology and Metabolism Diseases, Pordenone Hospital, Pordenone, Italy.

Silvia Grazioli (S)

Internal Medicine, Santa Maria degli Angeli Hospital, Pordenone, Italy.

Giorgio Zanette (G)

Clinic of Endocrinology and Metabolism Diseases, Pordenone Hospital, Pordenone, Italy.

Maurizio Tonizzo (M)

Internal Medicine, Santa Maria degli Angeli Hospital, Pordenone, Italy.

Classifications MeSH